ArticleFrontiers in endocrinology2025

Switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, may substantially reduce serum urate levels, through URAT1 inhibition, potentially without adversely affecting ABCG2 function: findings from the SWITCH SURI study.

Takeshi Osonoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.